文献速递慢阻肺

慢阻肺与心血管疾病风险增加相关且独立于表型

COPD is associated with increased cardiovascular disease risk independent of phenotype.
PubMed 文献 · Respirology · 2024-07-17

基于美国国家健康与营养调查(1999-2018)31,560名成人(含2,504例慢阻肺)的数据,分析慢阻肺表型与心血管疾病患病风险的关系。结果显示所有慢阻肺表型患者心血管疾病风险均显著升高,其中慢性支气管炎合并肺气肿表型风险最高(OR 2.98,95%CI 2.11-4.21),提示需重视慢阻肺患者的心血管筛查。

要点

  • 慢阻肺患者心血管疾病风险升高,且独立于肺气肿或慢性支气管炎表型。
  • 慢性支气管炎表型心血管疾病风险OR为1.76(95%CI 1.41-2.20)。
  • 肺气肿表型OR为2.31(95%CI 1.80-2.96),合并表型OR最高达2.98。

核心结论

  • 慢阻肺患者在所有表型中均存在心血管疾病风险升高,以慢性支气管炎合并肺气肿表型最为显著。

研究设计与样本

  • 研究利用美国国家健康与营养调查(NHANES)1999-2018年数据,共纳入31,560名成人,其中2,504例慢阻肺患者。

主要发现

  • 慢阻肺患者冠心病、心力衰竭、心肌梗死和卒中风险均显著增加。
  • 与无慢阻肺者相比,慢性支气管炎表型心血管疾病报告比值比为1.76(95%CI 1.41-2.20)。
  • 肺气肿表型心血管疾病报告比值比为2.31(95%CI 1.80-2.96)。
  • 慢性支气管炎合并肺气肿表型心血管疾病报告比值比为2.98(95%CI 2.11-4.21)。

临床怎么用

  • 临床应提高对慢阻肺患者心血管疾病的关注,并进行适当的心血管筛查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Chronic obstructive pulmonary disease (COPD) is a leading cause of death worldwide that frequently presents with concomitant cardiovascular diseases. Despite the pathological distinction between individual COPD phenotypes such as emphysema and chronic bronchitis, there is a lack of knowledge about the impact of COPD phenotype on cardiovascular disease risk. Thus, this study aimed to utilize a nationally representative sample to investigate cardiovascular disease prevalence in patients with COPD with emphysema and chronic bronchitis phenotypes. METHODS: Data from 31,560 adults including 2504 individuals with COPD, collected as part of the National Health and Nutrition Examination Survey (1999-2018), were examined. RESULTS: A significantly increased cardiovascular disease risk, including coronary heart disease, heart failure, myocardial infarction and stroke, was identified in patients with COPD among all disease phenotypes. Particularly, compared to those without COPD, individuals with chronic bronchitis presented with 1.76 (95% CI: 1.41-2.20) times greater odds, individuals with emphysema with 2.31 (95% CI: 1.80-2.96) times greater odds, while those with a concurrent phenotype (combined chronic bronchitis and emphysema) exhibited 2.98 (95% CI: 2.11-4.21) times greater odds of reporting cardiovascular diseases. CONCLUSION: Our data confirms that patients with COPD present an elevated risk of developing cardiovascular disease among all phenotypes, with the most marked increase being in those with concurrent chronic bronchitis and emphysema phenotypes. These findings emphasize the need for awareness and appropriate cardiovascular screening in COPD.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Cobb K, Kenyon J, Lu J, et al. COPD is associated with increased cardiovascular disease risk independent of phenotype. Respirology. 2024. PMID: 39019777. doi:10.1111/resp.14799

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。